GI Innovation, Inc. (358570.KQ)
KRW 9790.0
(-4.39%)
KRW 9790.0
(-4.39%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.82 Billion KRW | -350.2% |
| 2022 | 1.92 Billion KRW | -20.24% |
| 2021 | 2.41 Billion KRW | -98.51% |
| 2020 | 162.55 Billion KRW | 45.82% |
| 2019 | 111.47 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 469.7 Million KRW | -74.55% |
| 2024 Q1 | 1.84 Billion KRW | 138.28% |
| 2023 FY | -4.82 Billion KRW | -350.2% |
| 2023 Q4 | -4.82 Billion KRW | -382.0% |
| 2023 Q3 | 1.71 Billion KRW | 4935.41% |
| 2023 Q2 | 33.96 Million KRW | 100.14% |
| 2023 Q1 | -23.97 Billion KRW | -1343.93% |
| 2022 Q2 | -8.88 Billion KRW | -367.41% |
| 2022 Q1 | -1.89 Billion KRW | -178.62% |
| 2022 Q3 | 1.55 Billion KRW | 117.53% |
| 2022 Q4 | 1.92 Billion KRW | 23.85% |
| 2021 Q3 | -1.67 Billion KRW | 0.0% |
| 2021 Q4 | 2.41 Billion KRW | 244.07% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| HLB Co., Ltd. | -46.18 Billion KRW | 89.558% |
| iNtRON Biotechnology, Inc. | -40.58 Billion KRW | 88.117% |
| BINEX Co., Ltd. | 45.34 Billion KRW | 110.635% |
| Bioneer Corporation | -3.9 Billion KRW | -23.408% |
| Anterogen.Co.,Ltd. | 8.35 Billion KRW | 157.742% |
| MEDIPOST Co., Ltd. | 14.81 Billion KRW | 132.553% |
| CrystalGenomics, Inc. | 8.99 Billion USD | 153.632% |
| Helixmith Co., Ltd | -24.42 Billion KRW | 80.256% |
| Chabiotech Co.,Ltd. | 388.94 Billion KRW | 101.24% |
| Medy-Tox Inc. | 49.58 Billion KRW | 109.726% |
| Peptron, Inc. | 4.86 Billion KRW | 199.053% |
| Amicogen, Inc. | 125.26 Billion KRW | 103.85% |
| Genexine, Inc. | 61.39 Billion KRW | 107.855% |
| HLB Therapeutics Co.,Ltd. | -13.68 Billion KRW | 64.765% |
| LegoChem Biosciences, Inc. | -56.05 Billion KRW | 91.397% |
| ALTEOGEN Inc. | 53.56 Billion KRW | 109.002% |
| PharmaResearch Co., Ltd. | -32.93 Billion KRW | 85.359% |
| SillaJen, Inc. | -13.89 Billion KRW | 65.285% |
| JETEMA, Co., Ltd. | 84.27 Billion KRW | 105.722% |
| OliX Pharmaceuticals,Inc | 27.37 Billion KRW | 117.617% |
| Genomictree Inc. | -43.43 Billion KRW | 88.897% |
| MedPacto, Inc. | -64 Billion KRW | 92.465% |
| D&D Pharmatech | -7.5 Billion KRW | 35.767% |
| EASY BIO,Inc. | 53.21 Billion KRW | 109.063% |